Congress Shows Signs of Doubt Over Medicaid Fee Changes

WASHINGTON -- Opposition to proposed changes to the pharmacy reimbursement formula for generic medications in the Medicaid program has been expressed by members of the House and Senate.

WASHINGTON -- Opposition to proposed changes to the pharmacy reimbursement formula for generic medications in the Medicaid program has been expressed by members of the House and Senate. The formula, which calls for a reimbursement rate of 250% of the manufacturer‘s price for the drug, is meant as a way to implement the Budget Deficit Reduction Act of 2005. The act proposed $8.4 billion in Medicaid cuts over a five-year period. Bipartisan letters, authored by Reps. Marion Berr

Register to view the full article

test - Advanced Registered User

Already a member? .